Dragutin Novosel1* and Matija Alanović2
1Glaserbergstrasse 23, CH-4056 Basel, Switzerland
2SIPA Elektronika d.o.o., Ruđera Boškovića 17, 47000 Karlovac, Croatia
*Corresponding Author: Dragutin Novosel, Glaserbergstrasse 23, 4056 Basel, Switzerland. E-mail: firstname.lastname@example.org
Received: October 23, 2020; Published: November 25, 2020
Recently, some concerns [1-3] have been raised about the reliability of data presented in the current paper , which reported results from a non-randomised phase 1/2 study of a novel vaccine from Russia. The critics of the study  concentrated on potential data inconsistencies [1-3] in figures and analyzed them visually (here we ignore theoretical discussions about special features of the vaccine and/or vector). However, the baseline data and results of the safety data should be considered as well.
Citation: Dragutin Novosela and Matija Alanovic. “Analysis of Consistency of Prime-boost Covid-19 Baseline and Safety Data". Acta Scientific Medical Sciences 4.12 (2020): 81-82.
Copyright: © 2020 Dragutin Novosela and Matija Alanovic. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.